Home » Newsletters » BioWorld Science

BioWorld Science

May 17, 2006

View Archived Issues

Hypercholesterolemia linked to prostate cancer risk

Analgesic efficacy of Avinza detailed in clinical trials

Parenteral peramivir active against influenza A in vivo

IS-2's potent antipoliovirus activity is mediated by modulation of early viral uncoating

Antigenics updates Q1 progress

AEterna Zentaris highlights Q1 pipeline advancements

Two-year denosumab efficacy unaffected by weight in postmenopausal women

Rosiglitazone neuroprotective in mouse model of cerebral ischemia

SOU-001 development discontinued at Sosei

Advanced Viral Research completes first part of patient enrollment in phase I trial for diabetes

GPC Biotech begins phase I evaluation of satraplatin/Xeloda combination for advanced solid tumors

Marshall Edwards licenses two oncology compounds from Novogen

VasoGenix Pharmaceuticals and Cleveland Clinic heart failure agreement

LTT Bio-Pharma redesigns AS-013 development strategy for CLI

Abbott begins patient enrollment in ZoMaxx clinical trial for coronary artery disease

Biothera completes phase I clinical trial for Imprime PGG

Virosome Biologicals' intranasal influenza vaccine successfully completes phase I trials

Merck & Co. prepares and tests novel calcium-activated potassium channel blockers for glaucoma

Recent patents impart new therapeutic agents for cancer

Neurocrine receives approvable and nonapprovable letters from FDA for indiplon for insomnia

Eisai begins mutual recognition procedure in U.K. for new Aricept indication

Novel formulation of pegaptanib demonstrates sustained release in vivo

Primate lentiviral vector promotes stable gene transfer in the retina in preclinical studies

Benzimidazole D-ribonucleoside derivatives tested against human cytomegalovirus

Dyax provides update on regulatory pathway for DX-88

MU-1140: Oragenics' promising antibiotic to combat hospital- and community-acquired infections

GTx initiates phase II clinical trial of ostarine

NicOx and Ferrer select NCX-1047 as development candidate in dermatology collaboration

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...
DEE-lightful: Praxis’ phase II results allow stock to flex its muscle
BioWorld
Positive efficacy results led to Praxis Precision Medicines Inc.’s phase II Embold study in developmental and epileptic encephalopathies (DEEs) being halted...